Inter-observer and intra-observer variability in reporting vaginal dose points for cervical cancer in high-dose-rate brachytherapy

PURPOSE: The ICRU 89 recommends reporting a set of vaginal dose points for cervical cancer treatments in order to quantify the goodness of implant. This vaginal dose reporting method for combined external beam radiotherapy and brachytherapy has been adopted by the EMBRACE II study protocol. Large va...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Contemp Brachytherapy
Autors principals: Carrasco, Nuria, Chimeno, Jose, Adrià-Mora, Mar, Pérez-Calatayud, María José, Ibáñez, Blanca, Carmona, Vicente, Celada, Francisco, Gimeno, Jose, Lliso, Françoise, Pérez-Calatayud, José
Format: Artigo
Idioma:Inglês
Publicat: Termedia Publishing House 2020
Matèries:
Original Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7207226/
https://ncbi.nlm.nih.gov/pubmed/32395138
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/jcb.2020.94494
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars